@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP485113.RAHNVW-6Em006y-FLn6R8PAomqeU-O3zhuou-OY1j987Y130_head { this: np:hasAssertion dgn-np:NP485113.RAHNVW-6Em006y-FLn6R8PAomqeU-O3zhuou-OY1j987Y130_assertion; np:hasProvenance dgn-np:NP485113.RAHNVW-6Em006y-FLn6R8PAomqeU-O3zhuou-OY1j987Y130_provenance; np:hasPublicationInfo dgn-np:NP485113.RAHNVW-6Em006y-FLn6R8PAomqeU-O3zhuou-OY1j987Y130_publicationInfo; a np:Nanopublication . dgn-np:NP485113.RAHNVW-6Em006y-FLn6R8PAomqeU-O3zhuou-OY1j987Y130_assertion a np:Assertion . dgn-np:NP485113.RAHNVW-6Em006y-FLn6R8PAomqeU-O3zhuou-OY1j987Y130_provenance a np:Provenance . dgn-np:NP485113.RAHNVW-6Em006y-FLn6R8PAomqeU-O3zhuou-OY1j987Y130_publicationInfo a np:PublicationInfo . } dgn-np:NP485113.RAHNVW-6Em006y-FLn6R8PAomqeU-O3zhuou-OY1j987Y130_assertion { miriam-gene:5728 a ncit:C16612 . lld:C0001430 a ncit:C7057 . dgn-gda:DGNe350ce196a956544fe35ce85f754da20 sio:SIO_000628 miriam-gene:5728, lld:C0001430; a sio:SIO_001121 . } dgn-np:NP485113.RAHNVW-6Em006y-FLn6R8PAomqeU-O3zhuou-OY1j987Y130_provenance { dgn-np:NP485113.RAHNVW-6Em006y-FLn6R8PAomqeU-O3zhuou-OY1j987Y130_assertion dcterms:description "[Current data indicate that each of these histologic subtypes is associated with distinct morphologic and molecular genetic alterations: high-grade serous and possibly endometrioid carcinomas most probably arise from surface epithelial inclusion glands with TP53 mutations and dysfunction of BRCA1 and/or BRCA2; low-grade serous carcinomas probably arise in a stepwise fashion in an adenoma-borderline tumor-carcinoma sequence from typical to micropapillary borderline tumors to low-grade invasive serous carcinoma via activation of the RAS-RAF signaling pathway secondary to mutations in KRAS and BRAF; mucinous carcinomas arise via an adenoma-borderline tumor-carcinoma sequence with mutations in KRAS; low-grade endometrioid carcinomas arise from endometriosis via mutations in CTNNB1 (the gene encoding beta-catenin) and PTEN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:15761464; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP485113.RAHNVW-6Em006y-FLn6R8PAomqeU-O3zhuou-OY1j987Y130_publicationInfo { this: dcterms:created "2016-05-13T12:45:25+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }